Literature DB >> 1694612

Defining minimal requirements for antibody production to peptide antigens.

G Goodman-Snitkoff1, L E Eisele, E P Heimer, A M Felix, T T Andersen, T R Fuerst, R J Mannino.   

Abstract

The role that individual determinants play in modulating the immune response of an organism to a pathogen is often obscured because of the complexity of the pathogen. In order to gain a better appreciation of the role of individual determinants in the immune response, a pathogen may be dissociated into smaller components, for example peptides representing specific epitopes. These isolated components are often poorly immunogenic and historically have required the use of adjuvants to stimulate antibody production. This report defines the minimal essential requirements for antibody production to a peptide in this system. These are the ability to stimulate both B- and T-helper lymphocytes, anchorage in a phospholipid complex and multivalency within the complex. When these conditions are met, no additional adjuvants are necessary. This procedure has allowed us to identify three distinct T-helper cell epitopes from HIV gp160. In addition, this information has been used to produce a simple, totally synthetic and highly immunogenic preparation for the production of antibodies to peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694612     DOI: 10.1016/0264-410x(90)90055-q

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.

Authors:  G Gregoriadis; Z Wang; Y Barenholz; M J Francis
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

2.  Immunogenicity of coiled-coil based drug-free macromolecular therapeutics.

Authors:  Miloslav Kverka; Jonathan M Hartley; Te-Wei Chu; Jiyuan Yang; Regina Heidchen; Jindřich Kopeček
Journal:  Biomaterials       Date:  2014-04-22       Impact factor: 12.479

3.  Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.

Authors:  Te-Wei Chu; Jindřich Kopeček
Journal:  Biomater Sci       Date:  2015-07       Impact factor: 6.843

4.  Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.

Authors:  L E Brown; D O White; C Agius; B E Kemp; N Yatzakis; P Poumbourios; D A McPhee; D C Jackson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.

Authors:  L T Chin; J Hinkula; M Levi; M Ohlin; B Wahren; C A Borrebaeck
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.